Levothyroxine Sodium
Product Images NDC 70934-152

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 70934-152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

70934 152 30 Master Bottle Label Approval Rev B 12 18

Label for Levothyroxine Sodium Tablets, USP 100 mcg (0.1 mg), containing 30 tablets. The label states it is Rx only, includes storage instructions to keep between 20° to 25°C with allowable excursions, and warns to keep out of reach of children. The label is prepared and repackaged by Northwind Pharmaceuticals, a Denton Pharma, Inc. DBA. Lot and expiration details appear on the right.*

FDA Label Image

Molecule Levothyroxine Sodium (Levothyroxine Sodium Tablets Usp 1)

Chemical structure of Levothyroxine sodium showing its iodine-substituted phenol groups and sodium salt form with water of hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.